Clinical trial
PMCF - Study on the Performance/Safety of SeQuent® Sirolimus-Coated Balloon (SCB, Investigational Device) in Patients With Coronary Artery Disease
NCT04470934 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PMCF - Study on the Performance/Safety of SeQuent® Sirolimus-Coated Balloon (SCB, Investigational Device) in Patients With Coronary Artery Disease
- Lead sponsor
- B. Braun Melsungen AG
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 30, 2021
- Completion date
- March 31, 2027
- Enrollment
- 1,302 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, myocardial ischaemia